vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and BuzzFeed, Inc. (BZFD). Click either name above to swap in a different company.

BuzzFeed, Inc. is the larger business by last-quarter revenue ($31.6M vs $19.2M, roughly 1.6× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -48.0%, a 41.2% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -12.4%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -12.4%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

APYX vs BZFD — Head-to-Head

Bigger by revenue
BZFD
BZFD
1.6× larger
BZFD
$31.6M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+47.1% gap
APYX
34.7%
-12.4%
BZFD
Higher net margin
APYX
APYX
41.2% more per $
APYX
-6.8%
-48.0%
BZFD
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
-12.4%
BZFD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
APYX
APYX
BZFD
BZFD
Revenue
$19.2M
$31.6M
Net Profit
$-1.3M
$-15.1M
Gross Margin
62.6%
Operating Margin
0.1%
-42.7%
Net Margin
-6.8%
-48.0%
Revenue YoY
34.7%
-12.4%
Net Profit YoY
71.9%
-21.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
BZFD
BZFD
Q1 26
$31.6M
Q4 25
$19.2M
$56.5M
Q3 25
$12.9M
$46.3M
Q2 25
$11.4M
$46.4M
Q1 25
$9.4M
$36.0M
Q4 24
$14.2M
$56.2M
Q3 24
$11.5M
$55.6M
Q2 24
$12.1M
$41.1M
Net Profit
APYX
APYX
BZFD
BZFD
Q1 26
$-15.1M
Q4 25
$-1.3M
$-26.8M
Q3 25
$-2.0M
$-7.4M
Q2 25
$-3.8M
$-10.8M
Q1 25
$-4.2M
$-12.7M
Q4 24
$-4.6M
$31.0M
Q3 24
$-4.7M
$2.1M
Q2 24
$-6.6M
$-7.5M
Gross Margin
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Operating Margin
APYX
APYX
BZFD
BZFD
Q1 26
-42.7%
Q4 25
0.1%
-43.7%
Q3 25
-6.5%
-12.9%
Q2 25
-22.6%
-7.5%
Q1 25
-32.4%
-38.1%
Q4 24
-21.4%
7.0%
Q3 24
-31.6%
2.8%
Q2 24
-45.7%
-13.6%
Net Margin
APYX
APYX
BZFD
BZFD
Q1 26
-48.0%
Q4 25
-6.8%
-47.4%
Q3 25
-15.4%
-16.1%
Q2 25
-33.2%
-23.3%
Q1 25
-44.0%
-35.2%
Q4 24
-32.5%
55.2%
Q3 24
-40.9%
3.8%
Q2 24
-54.0%
-18.2%
EPS (diluted)
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
$-0.72
Q3 25
$-0.20
Q2 25
$-0.28
Q1 25
$-0.33
Q4 24
$0.86
Q3 24
$0.05
Q2 24
$-0.19
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
BZFD
BZFD
Cash + ST InvestmentsLiquidity on hand
$31.7M
$6.8M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$36.8M
Total Assets
$66.8M
$169.1M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
BZFD
BZFD
Q1 26
$6.8M
Q4 25
$31.7M
$8.5M
Q3 25
$25.1M
$34.3M
Q2 25
$29.3M
$29.7M
Q1 25
$31.0M
$34.3M
Q4 24
$31.7M
$22.4M
Q3 24
$28.0M
$53.7M
Q2 24
$32.7M
$45.5M
Total Debt
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Stockholders' Equity
APYX
APYX
BZFD
BZFD
Q1 26
$36.8M
Q4 25
$14.5M
$49.4M
Q3 25
$5.8M
$75.9M
Q2 25
$7.3M
$81.1M
Q1 25
$10.5M
$93.8M
Q4 24
$14.2M
$104.8M
Q3 24
$11.0M
$71.7M
Q2 24
$14.7M
$67.2M
Total Assets
APYX
APYX
BZFD
BZFD
Q1 26
$169.1M
Q4 25
$66.8M
$188.1M
Q3 25
$57.4M
$211.2M
Q2 25
$58.2M
$210.4M
Q1 25
$60.2M
$203.2M
Q4 24
$64.8M
$221.4M
Q3 24
$60.7M
$276.5M
Q2 24
$65.4M
$272.9M
Debt / Equity
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
BZFD
BZFD
Operating Cash FlowLast quarter
$-2.5M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
$-2.5M
$-11.7M
Q3 25
$-3.5M
$1.7M
Q2 25
$-1.2M
$-10.1M
Q1 25
$-702.0K
$1.3M
Q4 24
$-2.9M
$-4.6M
Q3 24
$-4.4M
$9.6M
Q2 24
$-4.3M
$-12.4M
Free Cash Flow
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
$-2.8M
$-12.0M
Q3 25
$-4.1M
$892.0K
Q2 25
$-1.5M
$-10.5M
Q1 25
$-757.0K
$956.0K
Q4 24
$-3.2M
$-4.7M
Q3 24
$-4.6M
$9.3M
Q2 24
$-4.6M
$-12.5M
FCF Margin
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
-14.6%
-21.2%
Q3 25
-31.5%
1.9%
Q2 25
-13.2%
-22.7%
Q1 25
-8.0%
2.7%
Q4 24
-22.4%
-8.4%
Q3 24
-40.0%
16.7%
Q2 24
-38.0%
-30.5%
Capex Intensity
APYX
APYX
BZFD
BZFD
Q1 26
0.8%
Q4 25
1.4%
0.5%
Q3 25
4.0%
1.8%
Q2 25
2.3%
1.0%
Q1 25
0.6%
1.1%
Q4 24
1.7%
0.3%
Q3 24
1.3%
0.5%
Q2 24
2.4%
0.3%
Cash Conversion
APYX
APYX
BZFD
BZFD
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

BZFD
BZFD

Advertising$17.1M54%
Other$7.5M24%
Commerce and other$6.9M22%

Related Comparisons